Aia Group LTD Laboratory Corp Of America Holdings Transaction History

Aia Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$213.32 - $257.83 $2.34 Million - $2.83 Million	10,982 Added 1257.96%	11,855 $2.72 Million
Q4 2022 Jan 31, 2023	SELL	$203.72 - $248.97 $82,914 - $101,330	-407 Reduced 31.8%	873 $205,000
Q3 2022 Nov 04, 2022	SELL	$204.81 - $262.19 $161,595 - $206,867	-789 Reduced 38.13%	1,280 $262,000
Q2 2022 Aug 11, 2022	SELL	$213.86 - $277.87 $1.03 Million - $1.33 Million	-4,795 Reduced 69.86%	2,069 $485,000
Q1 2022 May 06, 2022	BUY	$259.82 - $298.18 $1.53 Million - $1.75 Million	5,879 Added 596.85%	6,864 $1.81 Million
Q4 2021 Feb 11, 2022	SELL	$271.6 - $314.21 $1.31 Million - $1.51 Million	-4,806 Reduced 82.99%	985 $309,000
Q3 2021 Nov 05, 2021	BUY	$274.82 - $308.34 $1.59 Million - $1.79 Million	5,791 New	5,791 $1.63 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

Stay updated on Aia Group LTD with notifications on news.